Health systems are increasingly collaborating with consumer genetic testing companies
Dozens of companies currently offer direct-to-consumer genetic tests for a variety of purposes
Aspects of market change, like pharmacogenomic (PGx) testing, has become increasingly incorporated into medical plan coverage
Genetic testing companies are forming a new coalition on best practices for handling DNA information and to promote the industry in Washington as lawmakers put more scrutiny on their privacy practices. Three companies — Ancestry, 23andMe and Helix, which provide DNA testing and analysis — formed the Coalition for Genetic Data Protection. The move comes […]
Pharmacogenomics is one of the key aspects of personalized medicine, focusing on how an individual’s DNA affects the way they respond to medications. All individuals have different genetic make-up so they respond differently to the same medication. Based on this insight, pharmacogenomics allows customized treatment for a wide range of health problems including; cardiovascular disease, […]